Reliable measurements of brain atrophy in individual patients with multiple sclerosis

INTRODUCTION: As neurodegeneration is recognized as a major contributor to disability in multiple sclerosis (MS), brain atrophy quantification could have a high added value in clinical practice to assess treatment efficacy and disease progression, provided that it has a sufficiently low measurement...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Brain Behav
Autors principals: Smeets, Dirk, Ribbens, Annemie, Sima, Diana M., Cambron, Melissa, Horakova, Dana, Jain, Saurabh, Maertens, Anke, Van Vlierberghe, Eline, Terzopoulos, Vasilis, Van Binst, Anne‐Marie, Vaneckova, Manuela, Krasensky, Jan, Uher, Tomas, Seidl, Zdenek, De Keyser, Jacques, Nagels, Guy, De Mey, Johan, Havrdova, Eva, Van Hecke, Wim
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2016
Matèries:
Methods
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5036437/
https://ncbi.nlm.nih.gov/pubmed/27688944
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.518
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars